CPIEX
Price
$21.63
Change
+$0.35 (+1.64%)
Updated
Sep 19 closing price
QLENX
Price
$15.71
Change
+$0.14 (+0.90%)
Updated
Sep 19 closing price
Ad is loading...

CPIEX vs QLENX

Header iconCPIEX vs QLENX Comparison
Open Charts CPIEX vs QLENXBanner chart's image
Counterpoint Tactical Equity I
Price$21.63
Change+$0.35 (+1.64%)
VolumeN/A
CapitalizationN/A
AQR Long-Short Equity N
Price$15.71
Change+$0.14 (+0.90%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
CPIEX vs QLENX Comparison Chart
Loading...
VS
CPIEX vs. QLENX commentary
Sep 20, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CPIEX is a Buy and QLENX is a Hold.

FUNDAMENTALS
Fundamentals
QLENX has more cash in the bank: 1.94B vs. CPIEX (186M). QLENX pays higher dividends than CPIEX: QLENX (18.52) vs CPIEX (2.11). CPIEX was incepted earlier than QLENX: CPIEX (9 years) vs QLENX (11 years). CPIEX is a more actively managed with annual turnover of: 391.00 vs. QLENX (0.00). QLENX has a lower initial minimum investment than CPIEX: QLENX (2500) vs CPIEX (100000). CPIEX annual gain was more profitable for investors over the last year : 30.75 vs. QLENX (24.28). QLENX return over 5 years is better than : 94.94 vs. CPIEX (73.50).
CPIEXQLENXCPIEX / QLENX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years11 years-
Gain YTD29.91520.762144%
Front LoadN/AN/A-
Min. Initial Investment10000025004,000%
Min. Initial Investment IRAN/AN/A-
Net Assets186M1.94B10%
Annual Yield % from dividends2.1118.5211%
Returns for 1 year30.7524.28127%
Returns for 3 years91.4789.23103%
Returns for 5 years73.5094.9477%
Returns for 10 yearsN/A121.35-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OM0.650.12
+22.39%
Outset Medical
FA19.660.16
+0.82%
First Advantage Corp
KRT25.94-0.01
-0.04%
Karat Packaging
UNM56.24-0.16
-0.28%
Unum Group
GLMD6.83-8.27
-54.77%
Galmed Pharmaceuticals Ltd